» Articles » PMID: 30607340

Inhibits SW480 Cells Growth by Apoptosis Induction

Overview
Journal Adv Pharm Bull
Date 2019 Jan 5
PMID 30607340
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Streptomyces sp., a dominant genus in Actinomycetes, is the source of a wide variety of secondary metabolites. Microbial metabolites can be utilized as novel anticancer agents; with fewer side effects. The present article illustrated the anti-carcinogenic effect of the ether extracted organic metabolites derived from Streptomyces bacteria on SW480 colon cancer cell line. MTT assay was performed in order to investigate the cytotoxicity effect of metabolites on SW480 cells. Apoptosis and cell cycle arrests were measured by flowcytometry. Morphological changes were indicated by Propidium iodide staining andP53 gene expression was evaluated by real-time PCR. Streptomyces Levis ABRIINW111 inhibited cell growth, increased Caspases 3 and reduced Ki67 expression in a concentration/time-dependent manner in SW40 cells. Metabolites increased subG1 phase (apoptosis) and also cell cycle arrest in G1, G---2/M and S phase. P53 gene expression followed Sw480 cells treatment significantly. Streptomyces sp. metabolites have anti-carcinogenic effect on colon cancer cells. Streptomyces Levis ABRIINW111 metabolites are a candidate for Colon cancer treatment.

Citing Articles

Characteristics of sphingomyelin metabolism in the MCF7 and BT474 radiotherapy‑resistant HER2‑positive breast cancer cell lines.

Kikuchi M, Monzen S, Horikoshi M, Tsuda S, Tatara Y, Wojcik A Oncol Lett. 2024; 28(4):471.

PMID: 39139746 PMC: 11319826. DOI: 10.3892/ol.2024.14604.


Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells.

Morino Y, Sugiyama H, Yamane K, Kikuchi M, Yamanaka T, Honda K Oncol Rep. 2024; 52(2).

PMID: 38963046 PMC: 11240863. DOI: 10.3892/or.2024.8768.


Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy.

Kvakova M, Kamlarova A, Stofilova J, Benetinova V, Bertkova I World J Gastroenterol. 2022; 28(27):3370-3382.

PMID: 36158273 PMC: 9346452. DOI: 10.3748/wjg.v28.i27.3370.


Therapeutic applications and biological activities of bacterial bioactive extracts.

Abdelghani Z, Hourani N, Zaidan Z, Dbaibo G, Mrad M, Hage-Sleiman R Arch Microbiol. 2021; 203(8):4755-4776.

PMID: 34370077 PMC: 8349711. DOI: 10.1007/s00203-021-02505-1.


KJ623766: A Natural Producer of Two Anthracycline Cytotoxic Metabolites β- and γ-Rhodomycinone.

Abu Zaid A, Aleissawy A, Yahia I, Yassien M, Hassouna N, Aboshanab K Molecules. 2021; 26(13).

PMID: 34209170 PMC: 8271628. DOI: 10.3390/molecules26134009.


References
1.
Gottlieb T, Oren M . p53 and apoptosis. Semin Cancer Biol. 1999; 8(5):359-68. DOI: 10.1006/scbi.1998.0098. View

2.
Chang J, Powles T, Allred D, Ashley S, Clark G, Makris A . Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol. 1999; 17(10):3058-63. DOI: 10.1200/JCO.1999.17.10.3058. View

3.
Surh Y . Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res. 1999; 428(1-2):305-27. DOI: 10.1016/s1383-5742(99)00057-5. View

4.
Dardes R, Horiguchi J, Jordan V . A pilot study of the effects of short-term tamoxifen therapy on Ki-67 labelling index in women with primary breast cancer. Int J Oncol. 1999; 16(1):25-30. DOI: 10.3892/ijo.16.1.25. View

5.
Lipponen P . Apoptosis in breast cancer: relationship with other pathological parameters. Endocr Relat Cancer. 2000; 6(1):13-6. DOI: 10.1677/erc.0.0060013. View